Palbociclib, ribociclib & abemaciclib: important side-effect update
Recently, the US FDA issued a warning about a rare but severe side-effect experienced by patients taking any of the drugs palbociclib, ribociclib & abemaciclib.
More specifically, new findings from the regulatory agency in the USA have identified a rare side-effect. Patients taking this drug may experience severe lung inflammation. This is a serious and dangerous condition that requires immediate medical attention.
The FDA mentions that the symptoms to watch for include:
Difficulty or discomfort with breathingShortness of breath while at rest or with low activity.
Unfortunately, it is not clear at this time whether this side-effect depends on any specific risk factors.
It is important to talk to your medical team about this potential side-effect. As you know, all medicines have side effects, but in general the benefits outweigh the risks. Do not stop taking your medicine without first talking to your medical team.
I definitely speak w my oncologist in my next appointment.